GE HealthCare

GE HealthCare, a prominent company in the medical, precision, and optical instruments industry, based in the US, has outlined significant carbon emission reduction targets and climate commitments.

For the fiscal year 2025, GE HealthCare reported total emissions of approximately 5,915,000,000 kg CO2e. This breaks down into approximately 103,858,000 kg CO2e for Scope 1, and approximately 103,000,000 kg CO2e for Scope 2 (market-based). Scope 3 emissions were significantly higher, totalling approximately 5,565,623,000 kg CO2e, with the largest contribution coming from the use of sold products (approximately 3,256,930,000 kg CO2e) and purchased goods and services (approximately 1,160,847,000 kg CO2e).

In 2024, the company's total emissions were approximately 6,045,000,000 kg CO2e, comprising approximately 105,000,000 kg CO2e for Scope 1 and approximately 116,000,000 kg CO2e for Scope 2 (market-based). Scope 3 emissions for 2024 amounted to approximately 5,707,000,000 kg CO2e.

GE HealthCare is committed to achieving net zero GHG emissions across its value chain by 2050. As an interim goal, the company aims to reduce its operational emissions (Scope 1 and 2) by 42% by 2030, using a 2022 baseline. Additionally, a 25% reduction in specific Scope 3 emissions – covering purchased goods and services, upstream transportation and distribution, business travel, and the use of sold products – is targeted for the same timeframe.

Further evidence of their commitment includes a near-term target to reduce Scope 1 and 2 market-based GHG emissions by 50% by 2030, compared to a 2019 baseline. The company also has a long-term commitment to reduce absolute Scope 1, 2, and 3 GHG emissions by 90% by 2050, from a 2022 base year, as recognised by the Science Based Targets initiative (SBTi). GE HealthCare's SBTi targets align with a 1.5°C warming pathway.